Roivant Sciences (ROIV) Inventory (2023 - 2024)
Roivant Sciences' (ROIV) quarterly Inventory came in at $34.0 million in Q2 2024, up 704.66% YoY from $4.2 million in Q3 2023, and down 3.56% on a QoQ basis from $35.3 million in Q1 2024.
Roivant Sciences (ROIV) Inventory (2023 - 2024) Analysis & Trends
Roivant Sciences (ROIV) has 2 years of Inventory data on file, last reported at $34.0 million in Q2 2024.
- Quarterly Inventory rose 704.66% year-over-year to $34.0 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $34.0 million (up 704.66% YoY) and the FY2024 annual result came in at $35.3 million, up 1176.75% from the prior year.
- Inventory fell to $34.0 million in Q2 2024, from $35.3 million in the prior quarter.
- In the past five years, Inventory ranged from a high of $35.3 million in Q1 2024 to a low of $2.8 million in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 371.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 732.60 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 358,916.96 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 97.11 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 142.38 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 34.00 Mn |
| Mar 31, 2024 | 35.25 Mn |
| Dec 31, 2023 | 5.24 Mn |
| Sep 30, 2023 | 4.91 Mn |
| Jun 30, 2023 | 4.23 Mn |
| Mar 31, 2023 | 2.76 Mn |